Alpha 2.0
Login Register
» Articles » PMID: 31310321

Pattern-Corrected Mitotic Activity Index (PMAI): A Novel Prognosticator of Oral Squamous Cell Carcinoma

Overview
Journal Turk Patoloji Derg
Specialty Pathology
Date 2019 Jul 17
PMID 31310321
Citations 1
Authors
Nunna Sai Chitra
Karen Boaz
Srikant N
Amitha J Lewis
Sneha K S
Affiliations
Soon will be listed here.
Abstract

Objective: The main aim was to assess the efficiency of the Mitotic Activity Index (MAI) and a novel index devised by us, the Pattern-Corrected Mitotic Activity Index (PMAI) in prognostication of Oral Squamous Cell Carcinoma in terms of lymph node involvement, margin, recurrence and survival status.

Material And Method: The study group consisted of 60 cases of histologically-proven Oral Squamous Cell Carcinoma with known status of prognostic indicators. Hematoxylin and eosin stained sections of the tumor proper were utilized for assessment of mitotic activity and pattern of invasion. The Mitotic Activity Index and Pattern-Corrected Mitotic Activity Index were then calculated and correlated with the prognosticators.

Results: Mitotic Activity Index was higher in patients who had better survival and low recurrence rates. Pattern-Corrected Mitotic Activity Index showed the greatest percentage increase in relation to lymph node involvement as compared to the other indices. Kaplan Meier survival analysis showed that a higher Pattern-Corrected Mitotic Activity Index ( > 1.45) was associated with poorer survival (37.19 months).

Conclusion: Lack of significant association of the Mitotic Activity Index in relation to prognosticators could be attributed to a tumor having a migratory phenotype rather than a proliferative phenotype as seen in late-stage tumors. Late-stage tumors have more of a poorer pattern of invasion which is reflected best by Pattern-Corrected Mitotic Activity Index by correlating with poorer survival and lymph node involvement.

Citing Articles

Mitosis - predicting primary tumour and metastatic lymph node behaviour and beyond in OSCC - A pilot study.

Makarla S, Bavle R, Topajiche S J Oral Maxillofac Pathol. 2025; 28(4):602-611.

PMID: 39949704 PMC: 11819642. DOI: 10.4103/jomfp.jomfp_292_24.

The value of Phosphohistone H3 as a cell proliferation marker in oral squamous cell carcinoma. A comparative study with Ki-67 and the mitotic activity index.

Tancredi-Cueto N, Vigil-Bastitta G, Bologna-Molina R, Beovide-Cortegoso V Med Oral Patol Oral Cir Bucal. 2022; 27(5):e444-e451.

PMID: 35975799 PMC: 9445610. DOI: 10.4317/medoral.25420.

References
1.
Davies L, Hardin N, Beatty B . Can Ki-67 predict recurrence of NO squamous cell carcinoma of the tongue?. Ann Otol Rhinol Laryngol. 2006; 115(1):12-7. DOI: 10.1177/000348940611500102. View
2.
Freudlsperger C, Rohleder S, Reinert S, Hoffmann J . Predictive value of high Ki-67 expression in stage I oral squamous cell carcinoma specimens after primary surgery. Head Neck. 2010; 33(5):668-72. DOI: 10.1002/hed.21502. View
3.
Bryne M, Koppang H, Lilleng R, Stene T, Bang G, Dabelsteen E . New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med. 1989; 18(8):432-7. DOI: 10.1111/j.1600-0714.1989.tb01339.x. View
4.
van Diest P, Brugal G, Baak J . Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol. 1999; 51(10):716-24. PMC: 500923. DOI: 10.1136/jcp.51.10.716. View
5.
Dissanayaka W, Pitiyage G, Kumarasiri P, Liyanage R, Dias K, Tilakaratne W . Clinical and histopathologic parameters in survival of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 113(4):518-25. DOI: 10.1016/j.oooo.2011.11.001. View